A supplement bottle and a packet of medicine look similar and sit on adjacent shelves, but they have passed through entirely different regulatory routes. The difference explains most of what appears and does not appear on the label.

The two sit in different legal categories

In most jurisdictions, a medicine must demonstrate that it works for a stated condition and that its benefits outweigh its risks before it can be sold at all.

Supplements are generally regulated as a category of food. The presumption is that the ingredient is safe, and the burden falls on regulators to demonstrate otherwise after it is on sale.

This is a policy choice rather than a scientific judgement, and the boundaries differ considerably between countries and change over time.

Claims are constrained by category, not by evidence

Because a supplement is not a medicine, it cannot legally claim to treat, prevent or cure a condition. That constraint shapes the phrasing on every label.

What is permitted instead are general statements about supporting a normal bodily function, which are drawn from approved lists rather than from the specific product's own testing.

The vagueness readers notice is therefore a legal artefact. A precise claim would move the product into the medicines category.

Content is not verified the way potency is in medicines

Pharmaceutical manufacturing requires demonstrated consistency between batches, with the active ingredient present at the stated amount within narrow limits.

Supplement manufacturing standards vary. Independent testing programmes exist precisely because label content and actual content do not always match.

Products containing botanical extracts are the hardest case, since the concentration of the compound of interest varies with growing conditions and extraction method.

Adverse effects are reported differently

Medicines carry systematic post-marketing surveillance, with clinicians and patients reporting suspected reactions into a formal system.

Supplements are covered by weaker reporting arrangements, and because users do not consider them drugs, they frequently omit them when listing what they take.

That omission matters clinically, since some supplement ingredients interact with prescribed medication through the same liver enzymes.

Why this changes how a label should be read

The absence of a warning is not evidence of safety, and the absence of a claim is not evidence that a product does nothing.

What the label reliably conveys is the ingredient list and the amount claimed. Everything beyond that has been shaped by what the category permits.

Anyone taking prescribed medication, pregnant, or managing a diagnosed condition should raise any supplement with a pharmacist or clinician rather than judging it from the packaging.